Stock Ticker

  • Loading stock data...

What’s Latest With Durata Therapeutics Inc (NASDAQ:DRTX); WSP Holdings Limited (ADR) (NYSE:WH) And SmartPros Ltd. (NASDAQ:SPRO)?

Boston, MA 03/20/2014 (wallstreetpr) – Durata Therapeutics Inc (NASDAQ:DRTX)‘s lead product dalbavancin can become an important catalyst for the company as it is up for approval from the FDA. It is to be noted that Durata acquired the rights of dalbavancin from its previous owner, Pfizer, who did not proceed with the new requirement of […]